Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
7.70
0.12 (1.52%)
At close: Aug 15, 2025, 3:59 PM
7.70
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Aligos Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.86M | 43.09M | -82.15M | -19.26M | 5.06M | -34.86M | -27.89M | -18.04M | -18.79M | -22.95M | -21.89M | -18.62M | -19.92M | -35.62M | -37.71M | -33.13M | -29.82M | -27.67M |
Depreciation & Amortization | 259K | 194K | 671K | -119K | 610K | 674K | 775K | 681K | 769K | 844K | 897K | 906K | 889K | 983K | 1.01M | 967K | 925K | 873K |
Stock-Based Compensation | 1.16M | 959K | 1.71M | 2.04M | 2.06M | 2.65M | 2.58M | 3.21M | 3.2M | 3.66M | 3.42M | 3.49M | 4M | 3.79M | 3.65M | 3.6M | 3.45M | 2.76M |
Other Working Capital | 5.57M | -5.57M | -221K | 5.46M | 134K | -5.82M | 130K | -5.9M | 224K | -1.76M | -941K | -3.01M | -8.98M | 9.66M | -4.85M | 2.07M | 3.73M | -5.29M |
Other Non-Cash Items | -4.89M | -61.63M | 61.76M | -4.15M | -32.03M | 17.96M | 6.72M | 15.35M | 15.82M | -267K | -75K | -69K | -24K | 9K | 23K | 2K | 24K | 37K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -4.56M | -15.33M | -15.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.83M | -3.83M | -390K | 1.38M | 4.11M | -5.49M | -293K | -6.2M | 643K | -3.67M | 865K | -2.84M | -9.98M | 10.4M | -4.45M | 3.19M | 2.4M | -5.79M |
Operating Cash Flow | -15.5M | -20.91M | -18.4M | -20.1M | -19.49M | -22.75M | -22.66M | -20.34M | -13.62M | -22.39M | -16.78M | -17.14M | -25.04M | -20.43M | -37.48M | -25.37M | -23.02M | -29.8M |
Capital Expenditures | -109K | -43K | -28K | -26K | -7K | -69K | -7K | -12K | 7K | -7K | -91K | -3K | -334K | -515K | -336K | -97K | -152K | -307K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | 7K | n/a | -11.7M | -32.49M | 9.64M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -39.31M | -64.02M | n/a | -19.58M | n/a | -88.57M | n/a | -1K | -10K | n/a | -24.52M | -4.96M | -14.89M | -59.89M | -16.14M | -2.94M | n/a | n/a |
Sales Maturities Of Investments | n/a | 20M | 20M | 30M | 40M | n/a | n/a | 11K | 25M | 20M | 36.22M | 37.45M | 5.25M | n/a | n/a | 3M | 10M | 10M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 25M | 20M | 11.7M | 32.49M | -9.64M | -59.89M | -16.14M | 57K | 10M | 10M |
Investing Cash Flow | -39.42M | -44.07M | 19.97M | 10.4M | 39.99M | -88.64M | -7K | -9K | 25M | 19.99M | 11.6M | 32.48M | -9.98M | -60.4M | -16.48M | -40K | 9.85M | 9.69M |
Debt Repayment | n/a | n/a | -43K | -5K | -16K | -19K | -4K | -21K | -47K | -24K | 27K | -28K | -29K | -31K | -20K | -22K | -19K | -18K |
Common Stock Repurchased | n/a | n/a | n/a | -461K | 461K | n/a | -572K | 111K | 111K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 180K | n/a | 140K | 1K | 297K | n/a | 87.94M | n/a | 461K | n/a | 94K | n/a | 112K | 10K | 572K | 77.97M | 114K | 96K |
Financial Cash Flow | -177K | 101.74M | 97K | -4K | 281K | -19K | 87.94M | -21K | 414K | -1K | 121K | -19K | 83K | -21K | 552K | 77.95M | 95K | 78K |
Net Cash Flow | -55.1M | 36.77M | 1.67M | -9.71M | 20.78M | -111.41M | 65.27M | -20.37M | 11.8M | -2.4M | -5.06M | 15.33M | -34.93M | -80.86M | -53.41M | 52.54M | -13.07M | -20.02M |
Free Cash Flow | -15.61M | -20.95M | -18.43M | -20.13M | -19.5M | -22.82M | -22.66M | -20.35M | -13.61M | -22.39M | -16.87M | -17.14M | -25.37M | -20.95M | -37.82M | -25.46M | -23.17M | -30.1M |